We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Genomic Duplication Responsible for Rare Skin Disease

By LabMedica International staff writers
Posted on 15 May 2017
Through data analysis, ancestry mapping, genomic comparison, and international collaboration, researchers have identified the genetic mutation that causes the rare skin disease keratolytic winter erythema (KWE), or “Oudtshoorn skin,” in South African and Norwegian families.

Researchers at University of the Witwatersrand led the study in collaboration with peers in Europe, the USA, and Canada. More...
KWE causes a redness of the palms and soles with consecutive cycles of peeling of large sections of thick skin, often exacerbated during winter months. Oudtshoorn is a town in the Western Cape province of South Africa where the disorder was present in large families.

Afrikaners, the Afrikaans-language speakers descended from predominantly Dutch, German, and French settlers in South Africa, have a high risk for several genetic disorders (e.g. familial hypercholesterolaemia, porphyria, and the lesser known KWE) because of founder mutations brought by small groups who settled in the Cape of Good Hope and whose descendants are now spread throughout South Africa.

In 1977 KWE was found to occur with a dominant mode of inheritance (so, on average, if a parent has the condition about half the children inherit it in every generation). This early research has enabled dermatologists to make a definitive diagnosis and helped researchers better understand similar skin disorders.

In 1997, student Michelle Starfield guided by Michèle Ramsay, professor at Witz, and a group in Germany mapped the KWE trait to a region on the short arm of chromosome 8. The researchers showed that it was likely that the South African families all had the same mutation but that the German family had a different mutation. Later research focused on characterizing this region of the genome and examining good candidate genes. The KWE mutation remained elusive.

Subsequently, Wits student Thandiswa Ngcungcu, supervised by Prof. Ramsay, investigated KWE with large-scale DNA sequencing during an internship in Novartis, Basel. The mutation was not detected by conventional data analysis so copy-number variants (duplications or deletions) were investigated. Ngcungcu and colleagues discovered a duplication mutation in a genomic region between genes that was present in all South African KWE-affected individuals studied.

During this time Dr Torunn Fiskerstrand, University of Bergen, Norway, independently discovered a genomic duplication as the cause KWE in Norwegians. Ramsay and Fiskerstrand collaborated. The different DNA duplications in the South African and Norwegian families overlapped at a critical enhancer region, providing strong evidence that this was the KWE-causing mutation.

The scientists researched how this duplicated enhancer caused KWE and discovered that the mutation causes a nearby gene, CTSB, to produce more protein than normal and that this abnormal expression was the likely cause of the skin peeling disorder.

The study, by Ngcungcu T et al, was published in the May 2017 issue of the American Journal of Human Genetics.


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Rapid Test Reader
DIA5000
New
Silver Member
Autoimmune Hepatitis Test
LKM-1-Ab ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.